Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M&M Trial of mifepristone plus misoprostol for early pregnancy failure
NL-OMON43323Active, not recruiting
- Sponsor
- Radboudumc
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mifepristone, misoprostol and Placebo-COD Research Private Ltd in Pregnancy loss (2 arms), sponsored by Radboudumc. Primary endpoint: Complete evacuation of the uterus. Started Oct 2016; status: active, not recruiting.
02
Drugs
mifepristonemisoprostolPlacebo-COD Research Private Ltd
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on NL-OMON43323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43323.